Vol 7, Supplement 6 (December 20, 2018): Translational Andrology and Urology

Editorial

Cholesterol pathway the Achilles heel in prostate cancer metastasis

Isabel Heidegger, Renate Pichler, Andreas Pircher

PDF Pages: S686-S687 Full Text (1080) Open Access

Nutritional implications for quality of life in bladder cancer survivors

Charles J. Rosser

PDF Pages: S688-S691 Full Text (1314) Open Access

T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate

Andrew Brodie, Nadine McCauley, Jo Cresswell, Nikhil Vasdev

PDF Pages: S692-S695 Full Text (1130) Open Access

Will long term oncologic follow-up make the case for robotic assisted radical cystectomy?

Michael D. Gross, Bashir Al Hussein Al Awamlh, Jim C. Hu

PDF Pages: S696-S698 Full Text (1116) Open Access

Treating bladder adenocarcinoma

Georgios Tsironis, Aristotle Bamias

PDF Pages: S699-S701 Full Text (1970) Open Access

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer

Alina Vrieling

PDF Pages: S702-S705 Full Text (1217) Open Access

An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancers

Willem Oosterlinck, Karel Decaestecker

PDF Pages: S706-S709 Full Text (1372) Open Access

Does obesity impact bladder cancer prognosis?—a long-lasting debate

Fabrizio Dal Moro, Michele Colicchia

PDF Pages: S710-S711 Full Text (1812) Open Access

A retrosigmoid ileal conduit might prevent ureteroileal anastomotic stricture after ileal conduit diversion

Cristiano Mendes Gomes, Luccas Soares Laferreira

PDF Pages: S712-S714 Full Text (1643) Open Access

Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors

Kyoung-Hwa Lee, Ja Hyeon Ku

PDF Pages: S715-S717 Full Text (984) Open Access

Immunonutrition in radical cystectomy: a novel approach to reduce postoperative complications?

Atiqullah Aziz, Oliver W. Hakenberg

PDF Pages: S718-S719 Full Text (1054) Open Access

Do we have all the facts to determine the impact of bacillus Calmette-Guérin therapy on bladder cancer?

Ratha Mahendran

PDF Pages: S720-S722 Full Text (1206) Open Access

Editorial comment: bladder preservation as a treatment strategy in muscle-invasive bladder cancer

Khaled Ajib, Girish S. Kulkarni

PDF Pages: S723-S726 Full Text (926) Open Access

The patient’s perspective on blue light flexible cystoscopy: insight from a prospective clinical study

Nima Almassi, Eugene Pietzak

PDF Pages: S727-S728 Full Text (1397) Open Access

Redefining the role of immediate intravesical instillation of mitomycin C in non-muscle invasive bladder cancer

Deepak Batura

PDF Pages: S729-S731 Full Text (1105) Open Access

Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer

Matthew G. Kaag, Jay D. Raman

PDF Pages: S732-S734 Full Text (1469) Open Access

Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion?

Wei Shen Tan, John D. Kelly

PDF Pages: S735-S737 Full Text (1061) Open Access

High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer

Renate Pichler, Wolfgang Loidl, Martin Pichler

PDF Pages: S738-S740 Full Text (1635) Open Access

Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?

Ranjan Arianayagam, Anand Sharma, Nikhil Vasdev

PDF Pages: S741-S743 Full Text (984) Open Access

Does robotic radical cystectomy impede oncological outcome in bladder cancer patients?

Günter Niegisch

PDF Pages: S744-S746 Full Text (864) Open Access

Decreasing incidence of venous thromboembolic events after radical cystectomy: are we finally improving?

Benjamin T. Harper, Christopher J. D. Wallis, Zachary Klaassen

PDF Pages: S747-S750 Full Text (1207) Open Access

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?

Joseph Zabell, Badrinath Konety

PDF Pages: S751-S752 Full Text (1203) Open Access

Biomarkers for the prediction of oncologic outcomes in nonmuscle invasive bladder cancer: state of affairs and new frontiers

Francesco Soria, Shahrokh F. Shariat

PDF Pages: S753-S755 Full Text (1367) Open Access

Challenging the dogma of simultaneous resection of bladder tumor and benign prostate

Matvey Tsivian, Alexander Tsivian

PDF Pages: S756-S757 Full Text (912) Open Access

The timing of radical cystectomy following neoadjuvant chemotherapy

Venkat M. Ramakrishnan, Jairam R. Eswara

PDF Pages: S758-S759 Full Text (1118) Open Access

Impact of immunonutrition on radical cystectomy immunoresponse and outcomes; opportunity for peri-operative optimization

Marc A. Bjurlin, Angela B. Smith, William C. Huang

PDF Pages: S760-S762 Full Text (1372) Open Access

Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer

Ram Anil Pathak, Ashok K. Hemal

PDF Pages: S763-S764 Full Text (1130) Open Access

Letter to the Editor

The emerging role of PTBP1 in human cancer: novel prognostic factor in non-muscle invasive bladder cancer

Pamela Bielli, Savino M. Di Stasi, Claudio Sette

PDF Pages: S765-S767 Full Text (1364) Open Access

Response to editorial comment “A retrosigmoid ileal conduit might prevent ureteroileal anastomotic stricture after ileal conduit diversion”

Gianluca Giannarini, Alessandro Crestani, Vincenzo Ficarra

PDF Pages: S768-S769 Full Text (830) Open Access

News

Translational Andrology and Urology is indexed in SCIE: a milestone for the development of TAU

Editorial Office

PDF Pages: S770-S775 Full Text (1389) Open Access

Disclosure:

The supplement was published without any sponsorship or funding.